Crossmark

Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study

Published Online: 2019-09-11

Published Print: 2019-12

Authors

Rashid, Muhammad Usman

Muhammad, Noor

Naeemi, Humaira

Khan, Faiz Ali

Hassan, Mariam

Faisal, Saima

Gull, Sidra

Amin, Asim

Loya, Asif

Hamann, Ute http://orcid.org/0000-0001-6705-7624
Funding

Funding for this research was provided by:

Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore, Pakistan (ONC-BRCA-002)

German Cancer Research Center (DKFZ), Heidelberg, Germany
License Information

Text and Data Mining valid from 2019-09-11

Version of Record valid from 2019-09-11
More Information

Article History

Received: 23 May 2019

Accepted: 2 September 2019

First Online: 11 September 2019

Ethics approval and consent to participate

: This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. It was approved by the ethics committee of Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore Pakistan. The ethics committee name is the “Institutional Review Board”. The approval number is ONC-BRCA-002. Written informed consent was obtained from all study participants.

: Not applicable

: The authors declare that they have no competing of interests.

Document is current